# Bi‐Cheng Liu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bi-cheng-liu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,522 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 62 |
| i10-index | 203 |
| Last Known Institution | Zhongda Hospital Southeast University |
| OpenAlex ID | https://openalex.org/A5058396165 |
| ORCID iD | 0000-0002-4584-1853 |
| Works | 467 |

## Researcher papers

Showing 12 of 23.

- [Prevalence of chronic kidney disease in China: a cross-sectional survey](https://scholariq.org/papers/prevalence-of-chronic-kidney-disease-in-china-a-cross-sectional-survey/)
- [Renal tubule injury: a driving force toward chronic kidney disease](https://scholariq.org/papers/renal-tubule-injury-a-driving-force-toward-chronic-kidney-disease/)
- [The Novel Coronavirus 2019 epidemic and kidneys](https://scholariq.org/papers/the-novel-coronavirus-2019-epidemic-and-kidneys/)
- [Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis](https://scholariq.org/papers/roxadustat-treatment-for-anemia-in-patients-undergoing-long-term-dialysis/)
- [Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial](https://scholariq.org/papers/atrasentan-and-renal-events-in-patients-with-type-2-diabetes-and-chronic-kidney/)
- [Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis](https://scholariq.org/papers/roxadustat-for-anemia-in-patients-with-kidney-disease-not-receiving-dialysis/)
- [Acute kidney injury in China: a cross-sectional survey](https://scholariq.org/papers/acute-kidney-injury-in-china-a-cross-sectional-survey/)
- [Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury](https://scholariq.org/papers/exosomal-mirna-19b-3p-of-tubular-epithelial-cells-promotes-m1-macrophage/)
- [Epidemiology and Clinical Correlates of AKI in Chinese Hospitalized Adults](https://scholariq.org/papers/epidemiology-and-clinical-correlates-of-aki-in-chinese-hospitalized-adults/)
- [Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury](https://scholariq.org/papers/exosomal-mir-125b-5p-deriving-from-mesenchymal-stem-cells-promotes-tubular/)
- [Exosomal CCL2 from Tubular Epithelial Cells Is Critical for Albumin-Induced Tubulointerstitial Inflammation](https://scholariq.org/papers/exosomal-ccl2-from-tubular-epithelial-cells-is-critical-for-albumin-induced/)
- [Extracellular vesicle–encapsulated IL-10 as novel nanotherapeutics against ischemic AKI](https://scholariq.org/papers/extracellular-vesicle-encapsulated-il-10-as-novel-nanotherapeutics-against/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Extracellular vesicles in disease](https://scholariq.org/topics/extracellular-vesicles-in-disease/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

## Researcher university

- [Zhongda Hospital Southeast University](https://scholariq.org/institutions/zhongda-hospital-southeast-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.